Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-18
DOI
10.3389/fcell.2021.655950
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study
- (2020) Yue Yu et al. Journal of Thoracic Disease
- An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis
- (2020) Suzie K. Hight et al. NEOPLASIA
- DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model
- (2020) Zisheng Chen et al. Translational Lung Cancer Research
- Secular Trend of Cancer Death and Incidence in 29 Cancer Groups in China, 1990–2017: A Joinpoint and Age–Period–Cohort Analysis
- (2020) Xiaoxue Liu et al. Cancer Management and Research
- MITF functions as a tumor suppressor in non-small cell lung cancer beyond the canonically oncogenic role
- (2020) Yi-Jing Hsiao et al. Aging-US
- The current treatment landscape in the UK for stage III NSCLC
- (2020) Matthew Evison et al. BRITISH JOURNAL OF CANCER
- Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
- (2020) Giuseppe Lamberti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Upregulation of MAPK10, TUBB2B and RASL11B may contribute to the development of neuroblastoma
- (2019) Jiangtao Liu et al. Molecular Medicine Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Structural insights into the functional diversity of the CDK–cyclin family
- (2018) Daniel J. Wood et al. Open Biology
- RecQL4-Aurora B kinase axis is essential for cellular proliferation, cell cycle progression, and mitotic integrity
- (2018) Hongbo Fang et al. Oncogenesis
- PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
- (2018) Huaiyu Mi et al. NUCLEIC ACIDS RESEARCH
- Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
- (2017) et al. MOLECULES
- Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma
- (2017) Zhenzi Peng et al. Scientific Reports
- A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline
- (2016) Paul A. Rudnick et al. JOURNAL OF PROTEOME RESEARCH
- The impact of the Cancer Genome Atlas on lung cancer
- (2015) Jeremy T.-H. Chang et al. Translational Research
- Recent Clinical Advances in Lung Cancer Management
- (2014) David H. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers
- (2013) S. Rousseaux et al. Science Translational Medicine
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- The Human Protein Atlas-a tool for pathology
- (2008) F Pontén et al. JOURNAL OF PATHOLOGY
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search